Several NGOs protested Thursday at the annual meeting of Novartis against the attempt by the Swiss pharmaceutical group's India company to obtain a patent for its anti-cancer drug Glivec.
Feb 23, 2012
0
0
Researchers have shown that a novel antibody generated to target an 'essential amino acid sequence' of both interleukin-17A and F has greater activity and potentially fewer side effects than existing biological therapies ...
Aug 14, 2023
0
60
Researchers at the Department of Infection and Immunity of the Luxembourg Institute of Health (LIH) have developed LIH383, a novel molecule that binds to and blocks a previously unknown opioid receptor in the brain, thereby ...
Jun 19, 2020
0
80
Over a year into global COVID-19 vaccination efforts the question of whether jab formulas ought to be freely available is still unresolved—and undersupplied countries are turning to workarounds.
Jan 17, 2022
0
19
Pancreatitis is an inflammation of the pancreas that accounts for 275,000 hospitalizations in the United States annually. Patients who suffer from hereditary pancreatitis have a 40 to 50 percent lifetime risk of developing ...
Jun 20, 2019
0
1
PITTSBURGH (February 15, 2019) ... Neural stimulation is a developing technology that has beneficial therapeutic effects in neurological disorders, such as Parkinson's disease. While many advancements have been made, the ...
Feb 15, 2019
0
597
Supply of cheap, copycat drugs for the developing world could be badly threatened if Swiss firm Novartis wins a challenge to India's patent law, medical charity MSF said on Monday.
Sep 5, 2011
1
0
University of Birmingham researchers have invented a COVID-19 test that reduces testing time from 30 minutes to under five, and delivers accurate results.
Jan 5, 2021
0
33
Chronic kidney disease and eventual kidney failure are incurable diseases that affect 13% of the U.S. population, particularly those with high blood pressure and diabetes. These diseases degrade the "podocyte" cells of the ...
Aug 31, 2022
0
50
Researchers from the University of Birmingham are developing a rapid test for gum disease, and they expect the technology—a probe for use in point of care settings such as dental surgeries or pharmacies—to play a pivotal ...
Oct 13, 2022
0
27
